Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

A phase I study with the agonistic TRAIL-R1 antibody, mapatumumab, in combination with gemcitabine and cisplatin

A phase I study with the agonistic TRAIL-R1 antibody, mapatumumab, in combination with... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Oncology CrossRef

A phase I study with the agonistic TRAIL-R1 antibody, mapatumumab, in combination with gemcitabine and cisplatin

Oldenhuis, C.; Mom, C.; Sleijfer, S.; Gietema, J. A.; Fox, N. L.; Corey, A.; Eskens, F.; Loos, W.; de Vries, E. G.; Verweij, J.
Journal of Clinical Oncology , Volume 26 (15_suppl): 3540-3540 – May 20, 2008
Download PDF
Loading next page...
 
/lp/crossref/a-phase-i-study-with-the-agonistic-trail-r1-antibody-mapatumumab-in-8PYOEfNdad

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CrossRef
ISSN
0732-183X
DOI
10.1200/jco.2008.26.15_suppl.3540
Publisher site
See Article on Publisher Site

Abstract

Journal

Journal of Clinical Oncology – CrossRef

Published: May 20, 2008

There are no references for this article.